Pfizer acquires Biohaven Pharmaceutical, is this the biggest for the sector?

Be the First to Comment Read

Pfizer acquires Biohaven Pharmaceutical, is this the biggest for the sector?

On Tuesday Pfizer sealed their largest deal in years, with an $11.6 billion acquisition of Biohaven Pharmaceutical BHVN +68.39% a producer of migraine medication Nurtec ODT. Pfizer has been gaining from the demand of it’s Covid-19 vaccine and the Paxlovid Covid-19 oral anti-viral. Please watch this video to find out more. 

Disclaimer

Speak your Mind